These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 37972671

  • 1. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
    Nasri N, Saharkhiz S, Dini G, Yousefnia S.
    Int J Pharm; 2023 Dec 15; 648():123606. PubMed ID: 37972671
    [Abstract] [Full Text] [Related]

  • 2. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H, Wang M, Liu H, Liu X, Situ A, Wu B, Ji Z, Chang CH, Nel AE.
    ACS Nano; 2015 Dec 15; 9(4):3540-57. PubMed ID: 25776964
    [Abstract] [Full Text] [Related]

  • 3. Fabrication of Chitosan-coated Mesoporous Silica Nanoparticles Bearing Rosuvastatin as a Drug Delivery System.
    Ghahfarokhi MR, Dini G, Movahedi B.
    Curr Drug Deliv; 2022 Dec 15; 19(1):64-73. PubMed ID: 34151762
    [Abstract] [Full Text] [Related]

  • 4. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
    Li Z, Zhang Y, Zhu C, Guo T, Xia Q, Hou X, Liu W, Feng N.
    Int J Pharm; 2020 Aug 30; 586():119576. PubMed ID: 32603839
    [Abstract] [Full Text] [Related]

  • 5. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
    Zhang BB, Chen XJ, Fan XD, Zhu JJ, Wei YH, Zheng HS, Zheng HY, Wang BH, Piao JG, Li FZ.
    Acta Pharmacol Sin; 2021 May 30; 42(5):832-842. PubMed ID: 33824461
    [Abstract] [Full Text] [Related]

  • 6. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q, Chen X, Shi H, Dong G, Zhou M, Wang T, Xin H.
    Colloids Surf B Biointerfaces; 2017 Dec 01; 160():527-534. PubMed ID: 29024917
    [Abstract] [Full Text] [Related]

  • 7. PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect.
    Lin J, Cai Q, Tang Y, Xu Y, Wang Q, Li T, Xu H, Wang S, Fan K, Liu Z, Jin Y, Lin D.
    Int J Pharm; 2018 Jan 30; 536(1):272-282. PubMed ID: 29079221
    [Abstract] [Full Text] [Related]

  • 8. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z, Gong H, Liu M, Zhu H, Sun H.
    J Biomater Sci Polym Ed; 2016 Jan 30; 27(1):55-68. PubMed ID: 26540096
    [Abstract] [Full Text] [Related]

  • 9. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M, Chang C, Liu Z, Chen K, Zhou Y, Zheng G, Huang Z, Xu H, Xu P, Lu B.
    Colloids Surf B Biointerfaces; 2019 Nov 01; 183():110427. PubMed ID: 31408782
    [Abstract] [Full Text] [Related]

  • 10. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
    Al-Nadaf AH, Dahabiyeh LA, Jawarneh S, Bardaweel S, Mahmoud NN.
    Pharm Dev Technol; 2021 Jun 01; 26(5):582-591. PubMed ID: 33729906
    [Abstract] [Full Text] [Related]

  • 11. PEGylated mesoporous silica core-shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells.
    Shahbaz S, Esmaeili M, Fathian Nasab MH, Imani Z, Bafkary R, Amini M, Atyabi F, Dinarvand R.
    Int J Pharm; 2024 Apr 25; 655():124024. PubMed ID: 38537920
    [Abstract] [Full Text] [Related]

  • 12. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
    Mu S, Liu Y, Wang T, Zhang J, Jiang D, Yu X, Zhang N.
    Acta Biomater; 2017 Nov 25; 63():150-162. PubMed ID: 28873341
    [Abstract] [Full Text] [Related]

  • 13. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L, Zhu D, Dong X, Sun H, Song C, Wang C, Kong D.
    Int J Nanomedicine; 2015 Nov 25; 10():2101-14. PubMed ID: 25844039
    [Abstract] [Full Text] [Related]

  • 14. Antibody-conjugated pH-sensitive liposomes for HER-2 positive breast cancer: development, characterization, in vitro and in vivo assessment.
    Raikwar S, Yadav V, Jain S, Jain SK.
    J Liposome Res; 2024 Jun 25; 34(2):239-263. PubMed ID: 37594466
    [Abstract] [Full Text] [Related]

  • 15. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.
    Bafkary R, Ahmadi S, Fayazi F, Karimi M, Fatahi Y, Ebrahimi SM, Atyabi F, Dinarvand R.
    Daru; 2020 Jun 25; 28(1):171-180. PubMed ID: 32006342
    [Abstract] [Full Text] [Related]

  • 16. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L, Shen J, Li Z, Zhang D, Zhang Q, Duan C, Liu G, Zheng D, Liu Y, Tian X.
    Int J Pharm; 2012 Dec 15; 439(1-2):81-91. PubMed ID: 23078857
    [Abstract] [Full Text] [Related]

  • 17. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
    Dong S, Guo Y, Duan Y, Li Z, Wang C, Niu L, Wang N, Ma M, Shi Y, Zhang M.
    Anticancer Drugs; 2018 Aug 15; 29(7):637-645. PubMed ID: 29846247
    [Abstract] [Full Text] [Related]

  • 18. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
    Karuppaiah A, Babu D, Selvaraj D, Natrajan T, Rajan R, Gautam M, Ranganathan H, Siram K, Nesamony J, Sankar V.
    Eur J Pharm Sci; 2021 Oct 01; 165():105938. PubMed ID: 34256103
    [Abstract] [Full Text] [Related]

  • 19. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y, Li M, Liu T, Liu J, Xie Y, Zhang J, Xu S, Liu H.
    Int J Nanomedicine; 2019 Oct 01; 14():4029-4044. PubMed ID: 31213813
    [Abstract] [Full Text] [Related]

  • 20. Novel functional mesoporous silica nanoparticles loaded with Vitamin E acetate as smart platforms for pH responsive delivery with high bioactivity.
    Mai Z, Chen J, Hu Y, Liu F, Fu B, Zhang H, Dong X, Huang W, Zhou W.
    J Colloid Interface Sci; 2017 Dec 15; 508():184-195. PubMed ID: 28841476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.